Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Celgene Corporation (CELG)

« Back to company index

CELG Chatter Timeline

Stock Ticker for CELG

Most Active Tweeters for CELG

UserTweets
@DataTrials 11
@Biotech2050 5
@marketcycles 2
@FalconStocks 2
@JohnBCase 2

Recent Tweets for CELG

elitedu95 @elitedu95
RT @11Graphs: (6/8) Least expensive largest #Healthcare #Stocks by EV to EBITDA: 1. ?? PFIZER $PFE: 9.5x 2. ?? CELGENE $CELG: 10.6x 3. ?? C…
January 17th 2020, 3:01pm
11Graphs @11Graphs
(6/8) Least expensive largest #Healthcare #Stocks by EV to EBITDA: 1. ?? PFIZER $PFE: 9.5x 2. ?? CELGENE $CELG: 10.… https://t.co/jqbqS1rBmb
January 17th 2020, 1:01pm
Biotech2050 @Biotech2050
$TGTX #JPM build a whole team from ex $CELG!
January 16th 2020, 11:01am
StckPro @StckPro
$BMY $CELG NEW ARTICLE : Like AbbVie, Buy Allergan, It's A No-Brainer https://t.co/RFsm8vzGpf Get all the latest… https://t.co/pfOTHgwLQe
January 16th 2020, 11:01am
JasonWo33685755 @JasonWo33685755
@zipjet @Biotech2050 I've started out with $CELG but I've been on here screaming it from the top of my lungs! $BMY… https://t.co/USirkXQUKi
January 16th 2020, 10:01am
JohnBCase @JohnBCase
@jimcramer I did buy $BMY on your recommendation. The CO is very strong after the $CELG acquisition and has a treme… https://t.co/MXADt38TKM
January 15th 2020, 6:01pm
OlympiaReport @OlympiaReport
Celgene Co. $CELG Receives Average Rating of “Hold” from Brokerages https://t.co/PxkMKqJWE7
January 14th 2020, 9:01pm
WeekHerald @WeekHerald
Celgene Co. $CELG Receives $100.85 Average Price Target from Analysts https://t.co/N5uGGL65Lg
January 14th 2020, 9:01pm
DataTrials @DataTrials
$CELG Phase 1 A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients Wi… https://t.co/DbfvYXsQKt
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 2 Revlimid in Transfusion Dependent Patients…NCT01178814. Estimated Primary Completion Date - 02/2020
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 1|Phase 2 Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Brea… https://t.co/KzSzuLLAAt
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 1|Phase 2 Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for… https://t.co/OwKc1Kc5xR
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 2 Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML…… https://t.co/hiTFy0Fh3z
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 2 INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)…NCT02977780. Estimated Pr… https://t.co/zCCUW6Hvvb
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 2 A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Mye… https://t.co/5HVLUtSAhZ
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 1|Phase 2 Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients… https://t.co/21aGSw2Bu9
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 1 A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lym… https://t.co/VhvaZ7Kech
January 14th 2020, 3:01pm
DataTrials @DataTrials
$CELG Phase 1 A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers…NCT… https://t.co/598BnA6lEW
January 14th 2020, 2:01pm
_PharmaJon @_PharmaJon
$BMY and $CELG are the BIG fish in BIG pharma. Cancer, power, house. If the pipeline pans out of course. https://t.co/C3IF2TYDyL
January 13th 2020, 2:01pm
YuZhu4 @YuZhu4
RT @Biotech2050: $BMY included the 3 drugs triggering the CVR to ex $CELG holders in their #JPM20 presentation and CEO spoke with high conf…
January 13th 2020, 1:01pm
Biotech2050 @Biotech2050
$BMY included the 3 drugs triggering the CVR to ex $CELG holders in their #JPM20 presentation and CEO spoke with hi… https://t.co/xGp6q77G1v
January 13th 2020, 12:01pm
BursatilBiotech @BursatilBiotech
So buying $CELG along with the >12COs bought in the combo, was basically not enough. Ok, $BMY. #JPM20 https://t.co/s6b8pc17Yd
January 13th 2020, 10:01am
Biotech2050 @Biotech2050
RT @ScripMandy: $BMY Staying committed to oncology cell therapy programs gained in $CELG buyout that closed in November. Caforio highlighte…
January 13th 2020, 10:01am
ScripMandy @ScripMandy
$BMY Staying committed to oncology cell therapy programs gained in $CELG buyout that closed in November. Caforio hi… https://t.co/pYJQvsn8Jx
January 13th 2020, 10:01am
Biotech2050 @Biotech2050
@AgiosPharma Send our regards to Jackie Fouse from ex $CELG holders. You are in good hands.
January 13th 2020, 1:01am
TheMarketsDaily @TheMarketsDaily
Celgene Co. $CELG Given Average Recommendation of “Hold” by Brokerages https://t.co/ttgB39nTty
January 12th 2020, 1:01pm
stocknewstimes @stocknewstimes
Celgene Co. $CELG Receives Average Recommendation of “Hold” from Brokerages https://t.co/MJlbNHywNI
January 12th 2020, 1:01pm
newsfilterio @newsfilterio
Celgene Receives Average Recommendation of “Hold” from Brokerages $CELG https://t.co/OQR7J1vNXg
January 12th 2020, 1:01pm
JohnBCase @JohnBCase
@jimcramer After the $CELG merger, you recommended $BMY as a strong buy. I did my own independent analysis and came… https://t.co/HI6nP6JSFW
January 10th 2020, 10:01pm
marketcycles @marketcycles
Directional Bias for Invalid Iqfeed Symbol $CELG Trading Report https://t.co/joGSNe4ku0 Click for Details https://t.co/GNm6Nmzyx2
January 10th 2020, 9:01pm
marketcycles @marketcycles
Invalid Iqfeed Symbol $CELG Trading Report https://t.co/8lCC4Hw2PN Click for Buy/Sell
January 10th 2020, 9:01pm
DataTrials @DataTrials
$CELG Phase 3 Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Di… https://t.co/Y4mvKaxlgo
January 10th 2020, 3:01pm
Biotech2050 @Biotech2050
@dsobek The theft of the century for us ex $CELG holders. The great asset we acquired with $BMY is a visionary lead… https://t.co/n3MISpeiCW
January 10th 2020, 12:01pm
ThisLincolnian @ThisLincolnian
Celgene Co. $CELG Receives $100.85 Average PT from Brokerages https://t.co/GmLYmqxNii
January 10th 2020, 7:01am
StevenReznik @StevenReznik
RT @semodough: $BMY bought $CELG last year. At this time -Stock tanked - now year later setting at all time highs 65.70. -big takeovers c…
January 9th 2020, 3:01pm
newsfilterio @newsfilterio
Bristol-Myers confident of approvals linked to higher Celgene investor payout -Bristol exec $CELG^ $MRK https://t.co/mVwh96VFtG
January 9th 2020, 1:01pm
semodough @semodough
$BMY bought $CELG last year. At this time -Stock tanked - now year later setting at all time highs 65.70. -big ta… https://t.co/72wF0McZo2
January 9th 2020, 1:01pm
bbnsnews @bbnsnews
Head to Head Analysis: Amarin $AMRN vs. Celgene $CELG https://t.co/LwpHlgowTu
January 9th 2020, 4:01am
FalconStocks @FalconStocks
Another Double! . https://t.co/JX4QNct8lt 94% Avg Gain Listed Small & Penny Stock Ideas Our 15th Year! $CELG… https://t.co/wXE6CWmWxm
January 8th 2020, 10:01am
ZolmaxNews @ZolmaxNews
Celgene Co. $CELG Receives Average Recommendation of “Hold” from Analysts https://t.co/c1HgDaoUrv
January 7th 2020, 4:01pm
AmericanBanking @AmericanBanking
Celgene Co. $CELG Receives Average Rating of “Hold” from Brokerages https://t.co/fErhi0wr8D #stocks
January 7th 2020, 4:01pm
TickerReport @TickerReport
Celgene Co. $CELG Receives Average Rating of “Hold” from Brokerages https://t.co/2jCNCptvIs
January 7th 2020, 4:01pm
zipjet @zipjet
@skaushi @Biotech2050 And to the extent you got $BMY by owning $CELG you could have gotten another 10% off and the… https://t.co/82cC5RxSrQ
January 7th 2020, 1:01pm
FalconStocks @FalconStocks
. The signs and signals Market Makers send each other to move a stock: Article: https://t.co/V2nsljql1Q $CELG… https://t.co/jS8Y1Pt6RH
January 7th 2020, 11:01am
EnterpriseLeade @EnterpriseLeade
Amarin $AMRN and Celgene $CELG Head to Head Survey https://t.co/yaPEqoEe80
January 7th 2020, 3:01am
Coreh23 @Coreh23
Look at table (minus $celg). I am very intrigued by the complete responses seen with monotherapy for $tril and I do… https://t.co/vJS3T0D9CR
January 6th 2020, 5:01pm
WatchlistN @WatchlistN
Comparing Celgene $CELG and Amarin $AMRN https://t.co/Q19yAxy3A3
January 5th 2020, 1:01am
pharmamaven @pharmamaven
Thoughts on choppy $ZIOP Q4 (incl $CELG effect) & why we expect a rebound in January & new highs in 2020. Rosenberg… https://t.co/b0yzlxlmoS
January 2nd 2020, 3:01pm
pharmamaven @pharmamaven
@ThomasUBarton1 Thoughts on choppy $ZIOP Q4 (incl $CELG effect) & why we expect a rebound in January & new highs in… https://t.co/Wy4RySlhUq
January 2nd 2020, 3:01pm
TickerReport @TickerReport
Analyzing Amarin $AMRN & Celgene $CELG https://t.co/CRwLFWzQ5R
January 2nd 2020, 6:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.